Earlier this month, Goodwin Procter client Cowen Healthcare Royalty Partners, a global healthcare investment firm, announced the closing of a new $1 billion fund. Cowen Royalty exceeded its initial target for the fund by more than 75%.
Similar to its first fund, Cowen Royalty will target investments between $20 million and $100 million in the United States, Europe and Asia. It will primarily make capital investments in commercial stage biopharmaceutical and medical device companies in need of growth capital, and universities and inventors looking to monetize product interests.
“We have worked with Cowen Royalty since the firm’s inception, and we appreciate the opportunity to work with Cowen Royalty as they continue to grow their business. We wish them success and look forward to working with them in the future,” said Goodwin Procter partner Byron Pavano.
Founded in 2007, Cowen Healthcare Royalty Partners is a global healthcare investment firm with over $1.5 billion of capital under management. The Firm specializes in structured financing solutions for the life sciences industry. For more information, visit www.cowenroyalty.com.
The Goodwin Procter deal team was led by Pavano.